Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 11,741 shares, a decrease of 38.8% from the July 30th total of 19,190 shares. Based on an average trading volume of 22,301 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.5% of the company’s shares are sold short.
Innovator IBD 50 ETF Stock Performance
Shares of FFTY traded down $0.80 during mid-day trading on Tuesday, reaching $35.43. 13,885 shares of the company were exchanged, compared to its average volume of 58,676. The business has a 50 day simple moving average of $38.61 and a two-hundred day simple moving average of $38.46. The stock has a market capitalization of $76.17 million, a PE ratio of 30.34 and a beta of 1.47. Innovator IBD 50 ETF has a 52 week low of $31.61 and a 52 week high of $44.08.
Institutional Investors Weigh In On Innovator IBD 50 ETF
Several large investors have recently added to or reduced their stakes in the business. AlphaCore Capital LLC acquired a new position in Innovator IBD 50 ETF in the fourth quarter valued at approximately $32,000. International Assets Investment Management LLC acquired a new position in shares of Innovator IBD 50 ETF during the 4th quarter valued at $35,000. Simplex Trading LLC bought a new position in Innovator IBD 50 ETF during the fourth quarter worth $41,000. Advisory Services Network LLC acquired a new stake in Innovator IBD 50 ETF in the third quarter worth $43,000. Finally, Kestra Advisory Services LLC acquired a new stake in Innovator IBD 50 ETF in the fourth quarter worth $72,000.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
See Also
- Five stocks we like better than Innovator IBD 50 ETF
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
